Glucose monitors Specializing Company i-SENS Increases Sales by Advancing into European and Japanese Market
i-SENS began supplying products via OEM to large-sized European drug manufacturers, and concluded supply contract with the largest glucometer company in Japan to start targeting foreign market full-scale.
i-SENS CEO Geun-Sig Cha said “with just the fact that we have supplied to many big foreign companies, foreign buyers are acknowledging the technology of i-sens and sending supply inquiries.” and “We export test strips for glucose monitors where its quality is the same or better than other existing global companies’ products to Europe.”
Currently, i-SENS is selling its products to 52 countries across the world, and exports are responsible for more than 80% of i-Sens’ sales. Especially due to the increase in exports, the sales are expected to increase from 37.8 billion KRW in 2010 to 62 billion KRW this year.
The goal of i-SENS is to achieve No. 1 status in the domestic market within 3 years. More than half of the domestic market whose current size is 70 billion KRW is occupied by Roche of Switzerland and Johnson & Johnson of the U.S. i-Sens is ranked at the 3rd place in the domestic market, ahead of the domestic company Infopia.
CEO Geun Sig Cha said “we plan to strengthen R&D investment and marketing/publicity to expand our domain” and “we are also considering M&A with companies that may generate a synergy effect.”
Also, the company plans to be listed on the stock market the first half of next year, and based on its outstanding technology, it plans to take over the market by releasing new products such as glucose monitors applying new methods and electrolyte analyzer, etc. (Inquiries: +82-2-910-0687, jlee@i-sens.com)
Website: http://i-sens.com
Contact
i-Sens
+82-2-910-0687
Send Email
BNC Consulting
Eun-Young Nam
02-3443-0208
Send Email
This news is a press release provided by i-SENS, Inc..
-
2015년 10월 28일 09:30
